The Association for the Cannabinoid Industry today launched a free helpline for CBD companies wanting to continue operations in the UK after the FSA’s deadline of 31 March 2021.
On 13 February The FSA announced a new deadline that would have a huge impact on those operating in the UK CBD market. After 31 March 2021 only products with a validated novel foods application will be allowed to be sold online or in stores.
“The 31st March 2021 may seem a long way off,” explains Dr Parveen Bhatarah, Director of The ACI Regulatory and Compliance Unit, “but, you have to be aware of the amount of data that needs to be submitted to the FSA and EFSA. When taking into account the time governing bodies need to validate that data, if you have not started this process already there is a likelihood that you could miss this essential deadline.”
Research undertaken by The ACI experts outlines what a company must include in their novel foods dossier. It also highlights the need that companies should have already started this process in order to avoid disruption to their distribution channels. The ACI suggests companies set a deadline of October 2020 at the latest to submit their dossiers to the FSA and EFSA. This is to allow FSA/EFSA time to validate their submission.
Parveen concluded, “Companies need to generate multiple data sets for each of their products, this can be done in parallel, however some of this data can take up to 9 months to complete. Therefore, to submit a credible dossier by the end of 2020 it is paramount companies understand what they need to do right now.”
Given this information, CBD companies could be concerned as to their future. However, help is available and The ACI is here to support companies assess what exactly they need to do to produce their own robust novel foods CBD dossiers.